By Taylor Mixides (Drug Target Review)2023-06-01T16:00:10
Scientists have discovered that a vaccinated San Diego resident has produced antibodies that are effective against multiple variants of SARS-CoV-2, including Omicron. The research also identified three antibodies that can neutralise the virus, giving new insights into different binding mechanisms with the SARS-CoV-2 spike protein. The findings could help to ...
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-11T12:59:00Z
2026-06-24T13:00:00 2026-06-24T14:00:00
Sponsored by HUB Organoids
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2025-09-24T14:00:00
Sponsored by Eurofins Discovery
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2025-05-14T14:30:00
Sponsored by Abzena
2023-07-04T10:05:58
Sponsored by Revvity
Site powered by Webvision Cloud